{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:40:25Z","timestamp":1789782025510,"version":"4.0.1"},"reference-count":59,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/or.2017.5387","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T08:12:21Z","timestamp":1484727141000},"page":"1291-1300","source":"Crossref","is-referenced-by-count":41,"title":["Biology and function of glypican-3 as a candidate for early cancerous transformation of hepatocytes in hepatocellular carcinoma"],"prefix":"10.3892","volume":"37","author":[{"given":"Mauro","family":"Montalbano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremias","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlyn L.","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janika","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shirafkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Rastellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cicalese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"key20180107224240_b1-or-37-03-1291","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ijc.10856","article-title":"Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling","volume":"103","author":"Midorikawa","year":"2003","journal-title":"Int J Cancer"},{"key":"key20180107224240_b2-or-37-03-1291","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI200113712","article-title":"Glypicans: Proteoglycans with a surprise","volume":"108","author":"Filmus","year":"2001","journal-title":"J Clin Invest"},{"key":"key20180107224240_b3-or-37-03-1291","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0006-291X(03)00908-2","article-title":"Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker","volume":"306","author":"Nakatsura","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107224240_b4-or-37-03-1291","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.humpath.2006.05.016","article-title":"Glypican-3 expression in hepatocellular tumors: Diagnostic value for preneoplastic lesions and hepatocellular carcinomas","volume":"37","author":"Wang","year":"2006","journal-title":"Hum Pathol"},{"key":"key20180107224240_b5-or-37-03-1291","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3892\/ijo.2015.3312","article-title":"Transformation of primary human hepatocytes in hepatocellular carcinoma","volume":"48","author":"Montalbano","year":"2016","journal-title":"Int J Oncol"},{"key":"key20180107224240_b6-or-37-03-1291","doi-asserted-by":"crossref","first-page":"e0153613","DOI":"10.1371\/journal.pone.0153613","article-title":"Modeling of hepatocytes proliferation isolated from proximal and distal zones from human hepatocellular carcinoma lesion","volume":"11","author":"Montalbano","year":"2016","journal-title":"PLoS One"},{"key":"key20180107224240_b7-or-37-03-1291","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1349-7006.2003.tb01430.x","article-title":"Glypican-3 is overexpressed in human hepatocellular carcinoma","volume":"94","author":"Sung","year":"2003","journal-title":"Cancer Sci"},{"key":"key20180107224240_b8-or-37-03-1291","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10549-008-0009-2","article-title":"Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation","volume":"114","author":"Stigliano","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107224240_b9-or-37-03-1291","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/(SICI)1097-0177(199812)213:4<431::AID-AJA8>3.0.CO;2-7","article-title":"Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome","volume":"213","author":"Pellegrini","year":"1998","journal-title":"Dev Dyn"},{"key":"key20180107224240_b10-or-37-03-1291","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1165\/rcmb.2003-0061OC","article-title":"The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor","volume":"29","author":"Kim","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key20180107224240_b11-or-37-03-1291","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejca.2010.10.024","article-title":"Glypican-3: A new target for cancer immunotherapy","volume":"47","author":"Ho","year":"2011","journal-title":"Eur J Cancer"},{"key":"key20180107224240_b12-or-37-03-1291","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.22202","article-title":"Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma","volume":"47","author":"Lai","year":"2008","journal-title":"Hepatology"},{"key":"key20180107224240_b13-or-37-03-1291","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ajpath.2013.03.013","article-title":"Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex","volume":"183","author":"Bhave","year":"2013","journal-title":"Am J Pathol"},{"key":"key20180107224240_b14-or-37-03-1291","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/2047-783X-19-S1-S1","article-title":"Regenerative responses to liver injury","volume":"19","author":"Michalopoulos","year":"2014","journal-title":"Eur J Med Res"},{"key":"key20180107224240_b15-or-37-03-1291","first-page":"1333","article-title":"Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development","volume":"23","author":"Iglesias","year":"2008","journal-title":"Histol Histopathol"},{"key":"key20180107224240_b16-or-37-03-1291","first-page":"1993","volume-title":"[Internet]","author":"Golabi","year":"2006"},{"key":"key20180107224240_b17-or-37-03-1291","first-page":"71","article-title":"Glypican-3 (GPC3) expression in human placenta: Localization to the differentiated syncytiotrophoblast","volume":"16","author":"Khan","year":"2001","journal-title":"Histol Histopathol"},{"key":"key20180107224240_b18-or-37-03-1291","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/mgme.2001.3150","article-title":"Simpson Golabi Behmel syndrome: Progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition","volume":"72","author":"DeBaun","year":"2001","journal-title":"Mol Genet Metab"},{"key":"key20180107224240_b19-or-37-03-1291","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1309\/HCQWPWD50XHD2DW6","article-title":"Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: A tissue microarray analysis of 4,387 tissue samples","volume":"129","author":"Baumhoer","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"key20180107224240_b20-or-37-03-1291","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1158\/1078-0432.CCR-14-1170","article-title":"Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma","volume":"20","author":"Gao","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20180107224240_b21-or-37-03-1291","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.febslet.2013.10.002","article-title":"Glypican-3 antibodies: A new therapeutic target for liver cancer","volume":"588","author":"Feng","year":"2014","journal-title":"FEBS Lett"},{"key":"key20180107224240_b22-or-37-03-1291","first-page":"5179","article-title":"Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: Biological significance and temporospatial distribution","volume":"57","author":"Hsu","year":"1997","journal-title":"Cancer Res"},{"key":"key20180107224240_b23-or-37-03-1291","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1097\/01.pas.0000213322.89670.48","article-title":"Glypican 3: A novel marker in testicular germ cell tumors","volume":"30","author":"Zynger","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"key20180107224240_b24-or-37-03-1291","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1874079001508010012","article-title":"Expression of glypican-3 (GPC3) in malignant and non-malignant human breast tissues","volume":"8","author":"Castillo","year":"2015","journal-title":"Open Cancer J"},{"key":"key20180107224240_b25-or-37-03-1291","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1038\/sj.onc.1204925","article-title":"Glypican-3 expression is silenced in human breast cancer","volume":"20","author":"Xiang","year":"2001","journal-title":"Oncogene"},{"key":"key20180107224240_b26-or-37-03-1291","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1478-3231.2005.01100.x","article-title":"Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers","volume":"25","author":"Man","year":"2005","journal-title":"Liver Int"},{"key":"key20180107224240_b27-or-37-03-1291","first-page":"807","article-title":"Frequent silencing of the GPC3 gene in ovarian cancer cell lines","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107224240_b28-or-37-03-1291","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1158\/1078-0432.CCR-04-0348","article-title":"Identification of glypican-3 as a novel tumor marker for melanoma","volume":"10","author":"Nakatsura","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107224240_b29-or-37-03-1291","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.21328","article-title":"Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas","volume":"44","author":"Luo","year":"2006","journal-title":"Hepatology"},{"key":"key20180107224240_b30-or-37-03-1291","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2353\/ajpath.2009.081129","article-title":"Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation","volume":"175","author":"Liu","year":"2009","journal-title":"Am J Pathol"},{"key":"key20180107224240_b31-or-37-03-1291","first-page":"45","article-title":"Seroprevalence of Glypican-3 (GPC-3) in patients with pancreatic, gastric and esophageal cancers","volume":"4","author":"Ahmed","year":"2011","journal-title":"NY Sci J"},{"key":"key20180107224240_b32-or-37-03-1291","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000136159","article-title":"Immunohistochemical study of glypican 3 in thyroid cancer","volume":"73","author":"Yamanaka","year":"2007","journal-title":"Oncology"},{"key":"key20180107224240_b33-or-37-03-1291","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1309\/AJCP4NSKW5TLGTDS","article-title":"Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (\u2206Np63) in squamous cell and urothelial carcinoma","volume":"140","author":"Gailey","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"key20180107224240_b34-or-37-03-1291","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1349-7006.2009.01108.x","article-title":"Glypican 3-expressing gastric carcinoma: Distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas","volume":"100","author":"Ushiku","year":"2009","journal-title":"Cancer Sci"},{"key":"key20180107224240_b35-or-37-03-1291","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13000-015-0266-4","article-title":"Expression of Glypican 3 in low and high grade urothelial carcinomas","volume":"10","author":"Aydin","year":"2015","journal-title":"Diagn Pathol"},{"key":"key20180107224240_b36-or-37-03-1291","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2350\/12-06-1216-OA.1","article-title":"Immunohistochemical expression of glypican-3 in pediatric tumors: An analysis of 414 cases","volume":"16","author":"Chan","year":"2013","journal-title":"Pediatr Dev Pathol"},{"key":"key20180107224240_b37-or-37-03-1291","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1083\/jcb.141.6.1407","article-title":"OCI-5\/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner","volume":"141","author":"Gonzalez","year":"1998","journal-title":"J Cell Biol"},{"key":"key20180107224240_b38-or-37-03-1291","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.onc.1203322","article-title":"Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma","volume":"19","author":"Murthy","year":"2000","journal-title":"Oncogene"},{"key":"key20180107224240_b39-or-37-03-1291","doi-asserted-by":"crossref","first-page":"10185","DOI":"10.4238\/2015.August.28.2","article-title":"Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance","volume":"14","author":"Yu","year":"2015","journal-title":"Genet Mol Res"},{"key":"key20180107224240_b40-or-37-03-1291","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.humpath.2012.06.016","article-title":"Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms","volume":"44","author":"Mounajjed","year":"2013","journal-title":"Hum Pathol"},{"key":"key20180107224240_b41-or-37-03-1291","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/1471-2407-14-631","article-title":"GPC3 reduces cell proliferation in renal carcinoma cell lines","volume":"14","author":"Valsechi","year":"2014","journal-title":"BMC Cancer"},{"key":"key20180107224240_b42-or-37-03-1291","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.acthis.2011.10.003","article-title":"Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: A tissue microarray-based study","volume":"114","author":"Zhang","year":"2012","journal-title":"Acta Histochem"},{"key":"key20180107224240_b43-or-37-03-1291","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2046-4053-2-37","article-title":"Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: A systematic review and meta-analysis protocol","volume":"2","author":"Huang","year":"2013","journal-title":"Syst Rev"},{"key":"key20180107224240_b44-or-37-03-1291","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/jgh.12461","article-title":"Golgi protein 73, not Glypican-3, may be a tumor marker complementary to \u03b1-Fetoprotein for hepatocellular carcinoma diagnosis","volume":"29","author":"Wang","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180107224240_b45-or-37-03-1291","doi-asserted-by":"crossref","first-page":"e0151501","DOI":"10.1371\/journal.pone.0151501","article-title":"CK19 and Glypican 3 expression profiling in the prognostic indication for patients with HCC after surgical resection","volume":"11","author":"Feng","year":"2016","journal-title":"PLoS One"},{"key":"key20180107224240_b46-or-37-03-1291","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/hep.23794","article-title":"Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice","volume":"52","author":"Liu","year":"2010","journal-title":"Hepatology"},{"key":"key20180107224240_b47-or-37-03-1291","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1078-0432.CCR-12-2616","article-title":"First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma","volume":"19","author":"Zhu","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180107224240_b48-or-37-03-1291","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.febslet.2012.02.017","article-title":"MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3","volume":"586","author":"Huang","year":"2012","journal-title":"FEBS Lett"},{"key":"key20180107224240_b49-or-37-03-1291","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2310\/7290.2010.00048","article-title":"Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles","volume":"10","author":"Park","year":"2011","journal-title":"Mol Imaging"},{"key":"key20180107224240_b50-or-37-03-1291","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/acs.bioconjchem.6b00030","article-title":"Novel glypican-3-binding peptide for in vivo hepatocellular carcinoma fluorescent imaging","volume":"27","author":"Zhu","year":"2016","journal-title":"Bioconjug Chem"},{"key":"key20180107224240_b51-or-37-03-1291","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7150\/ijbs.6.769","article-title":"The glypican 3-hosted murine mir717 gene: Sequence conservation, seed region polymorphisms and putative targets","volume":"6","author":"Kunej","year":"2010","journal-title":"Int J Biol Sci"},{"key":"key20180107224240_b52-or-37-03-1291","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1665-2681(19)31267-0","article-title":"Obesity as a cause of hepatocellular carcinoma","volume":"14","author":"Kew","year":"2015","journal-title":"Ann Hepatol"},{"key":"key20180107224240_b53-or-37-03-1291","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.4161\/cc.7.18.6672","article-title":"The role of glypican-3 in the regulation of body size and cancer","volume":"7","author":"Filmus","year":"2008","journal-title":"Cell Cycle"},{"key":"key20180107224240_b54-or-37-03-1291","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1111\/febs.12126","article-title":"Glypican-3: A marker and a therapeutic target in hepatocellular carcinoma","volume":"280","author":"Filmus","year":"2013","journal-title":"FEBS J"},{"key":"key20180107224240_b55-or-37-03-1291","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/22336","article-title":"The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila","volume":"400","author":"Tsuda","year":"1999","journal-title":"Nature"},{"key":"key20180107224240_b56-or-37-03-1291","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1074\/jbc.M410090200","article-title":"The loss of glypican-3 induces alterations in Wnt signaling","volume":"280","author":"Song","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107224240_b57-or-37-03-1291","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","article-title":"Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling","volume":"65","author":"Capurro","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107224240_b58-or-37-03-1291","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/psc.1400","article-title":"Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand","volume":"17","author":"Lee","year":"2011","journal-title":"J Pept Sci"},{"key":"key20180107224240_b59-or-37-03-1291","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1478-3231.2010.02359.x","article-title":"Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma","volume":"31","author":"Yorita","year":"2011","journal-title":"Liver Int"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2017.5387\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T14:13:57Z","timestamp":1568729637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,18]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,1,18]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/or.2017.5387"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5387","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,18]]}}}